By Athena Vlachou Drugs used to treat metabolic disorders, such as Type 2 diabetes, alleviate symptoms of Alzheimer's disease ...

When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.

In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...

Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...

With 38% of U.S. adults living with high cholesterol, experts say understanding how statins work — and whether you need them ...

Statins are the go-to medications for lowering “bad” LDL cholesterol, reducing the risk of cardiovascular disease and ...

A new discovery may explain why so many people abandon cholesterol-lowering statins because of muscle pain and weakness.

Both types of juice contain immune-supporting vitamin C, while orange juice may show more promise for heart health overall, with less risk of drug interactions.

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

In question is Esperion’s Lipid Lurkers educational campaign, which was launched in July 2024 with support from agency ...